Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Conmed Corp shares valued at $150,500 were purchased by Garner Todd W on Nov 06 ’25. At $43.00 per share, Garner Todd W acquired 3,500 shares.
Also, Farkas Charles sold 2,000 shares, netting a total of over 107,049 in proceeds. Following the sale of shares at $53.52 each, the insider now holds 14,859 shares.
Before that, Farkas Charles had added 2,000 shares to its account. In a trade valued at $107,049, the Director bought Conmed Corp shares for $53.52 each.
As published in a research note from Needham on June 12, 2025, Conmed Corp [CNMD] has been rated down from a Buy to a Hold. Analysts at Stifel downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late April. As of February 06, 2025, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for CNMD. Earlier on February 01, 2024, Needham resumed its rating. Their recommendation was “a Buy” for CNMD stock.
Analyzing CNMD Stock Performance
On last trading session, Conmed Corp [NYSE: CNMD] plunged -0.52% to $44.21. The stock’s lowest price that day was $41.615, but it reached a high of $45.055 in the same session. During the last five days, there has been a drop of approximately -0.63%. Over the course of the year, Conmed Corp shares have dropped approximately -37.26%. Shares of the company reached a 52-week high of $74.70 on 02/05/25 and a 52-week low of $41.62 on 11/06/25.
Support And Resistance Levels for Conmed Corp (CNMD)
According to the 24-hour chart, there is a support level at 42.15, which, if violated, would cause prices to drop to 40.10. In the upper region, resistance lies at 45.73. The next price resistance is at 47.25. RSI (Relative Strength Index) is 39.78 on the 14-day chart, showing neutral technical sentiment.
Is Conmed Corp subject to short interest?
Stocks of Conmed Corp saw a sharp steep in short interest on 2025-10-15 dropping by 95594.0 shares to 2.1 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 2.19 million shares. A decline of -4.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.46 of the overall float, the days-to-cover ratio (short ratio) decline to 5.46.
Which companies own the most shares of Conmed Corp (CNMD)?
In terms of Conmed Corp share price expectations, FactSet research, analysts set an average price target of 78 in the next 12 months, up nearly 75.52% from the previous closing price of $44.44. Analysts anticipate Conmed Corp stock to reach 95 by 2025, with the lowest price target being 61. In spite of this, 4 analysts ranked Conmed Corp stock as Buy at the end of 2025. On May 22, 2023, CL King assigned a price target of “a Buy” to the stock and initiated coverage with a $140.
